yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33503399-31382503-A3DF-4E81-B222-F70A05B62E03
Q33503399-31382503-A3DF-4E81-B222-F70A05B62E03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33503399-31382503-A3DF-4E81-B222-F70A05B62E03
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain.
P2860
Q33503399-31382503-A3DF-4E81-B222-F70A05B62E03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33503399-31382503-A3DF-4E81-B222-F70A05B62E03
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
07dfd1d4fe99d21849701173942ce21a1e1f89e8
P2860
Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain.